Compliance, Medication, Compliance, Patient, Compliance, Treatment, Hypertension, Quality of Life, Self-Management
Conditions
Keywords
Hypertension, Self-Management, Resilience
Brief summary
Hypertension (HTN) rates have increased worldwide, but the most significant increase in the incidence of morbidity and mortality has been in African Americans (AA) (43% vs 27% for other U.S. population groups). Despite evidence of positive benefits from lifestyle modification (healthy diet, reduced sodium intake, increased physical activity, smoking cessation) and prescribed antihypertensive therapy (AHT) many AA with HTN do not adhere to their treatment regimens. Consistent, effective lifelong self-management is required to sustain optimal BP control and thus reduce morbidity and mortality. Self-managing HTN to a blood pressure (BP) \<130/80 mm Hg presents challenges such as juggling multiple medications and health care providers, dealing with complex recommendations and treatment regimens, and coping with negative emotional states. Few studies have examined the biopsychosocial mechanisms that foster effective HTN self-management and resilience among AA living with HTN. Understanding the mechanisms that influence HTN self-management and resilience in AA holds the promise of new modifiable targets for behavior-change interventions. This study explores the relationship among resilience precursors on hypertension (HTN) self-management behaviors, stress response, and the effects that these relationships have on health outcomes-health-related quality of life (HRQOL) and blood pressure (BP) in African Americans (AA) with HTN over a 6-month period.
Detailed description
This study identifies profiles of self-management and the resilience trajectories in AA with HTN can lead to culturally appropriate, patient-centered interventions that improve their HTN self-management, quality of life, and long-term compliance. This study aims to: 1. Assess the association among resilience precursors (dispositional optimism and resilience, emotion regulation); stress response (physiological: cortisol, interleukins \[IL-6\] and psychological: depression cognitions, perceived stress); hypertension self management behaviors (self-efficacy for chronic disease management, medication adherence to antihypertensives); and health outcomes (HQROL and BP) in AA with HTN at baseline and months 3 and 6. 2. Determine if stress response mediates the relationship between resilience precursors and health outcomes over time when controlling for risk regulators. 3. Determine if self-management behaviors mediates the relationship between resilience precursors and health outcomes over time when controlling for risk regulators. 4. Identify resilience trajectory patterns and factors that influence HTN self-management behaviors over time.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Self-identify as African American * 25 years of age or older * Diagnosed with hypertension and prescribed one antihypertensive medication * BP \>130/80 mmHg * Have at least one additional chronic health conditions * Able to read/understand English
Exclusion criteria
* Unable to give informed consent or judged to have impaired cognitive ability or severe memory * Have experienced a major CVD event or procedure (e.g., myocardial infarction, stroke, heart surgery) within the past year
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Systolic Blood Pressure | Baseline - 6 months | Measure of participants' in clinic blood pressure (average of three blood pressure readings). Defined as the Number (%) of participants who achieved Systolic Blood Pressure \< 130mmHg at Baseline and 6 months. |
| Diastolic Blood Pressure | Baseline - 6 months | Measure of participants' in clinic blood pressure (average of three blood pressure readings). |
| PROMIS Global Health-10 [Health-related Quality of Life] | Baseline - 6 months | PROMIS Global Health-10 is divided into 2 separate components: Global Physical Health and Global Mental Health. The possible score ranges from 0 to 20 points in each component, where 0 points represent the patient's most severe state of physical and/or mental health, while 20 points represent the best possible state of physical and/or mental health. A higher score indicates better quality in domains of physical and/or mental health and functioning. |
Countries
United States
Contacts
Case Western Reserve University, School of Nursing
Participant flow
Recruitment details
Participants were recruited from clinics affiliated with University Hospitals Cleveland Medical Center (UHCMC), community centers, clinician referrals, and targeted advertisements from 2022 to 2024.
Baseline characteristics
| Characteristic | — |
|---|---|
| Age, Customized Age | 62.66 Years STANDARD_DEVIATION 12.32 |
| Education Level College degree | 43 Participants |
| Education Level Graduated from high school | 21 Participants |
| Education Level Greater than high school/Trade School | 51 Participants |
| Education Level Less than high school | 9 Participants |
| Employment status Employed | 60 Participants |
| Employment status No reports on employment status | 7 Participants |
| Employment status Not employed | 57 Participants |
| Ethnicity (NIH/OMB) Hispanic or Latino | 0 Participants |
| Ethnicity (NIH/OMB) Not Hispanic or Latino | 124 Participants |
| Ethnicity (NIH/OMB) Unknown or Not Reported | 0 Participants |
| Insured Medicaid | 25 Participants |
| Insured Medicare | 29 Participants |
| Insured More than one insurance | 23 Participants |
| Insured Private | 43 Participants |
| Insured Veteran Benefits | 4 Participants |
| Marital Status Married | 38 Participants |
| Marital Status No reports on marital status | 1 Participants |
| Marital Status Single | 85 Participants |
| Race (NIH/OMB) American Indian or Alaska Native | 0 Participants |
| Race (NIH/OMB) Asian | 0 Participants |
| Race (NIH/OMB) Black or African American | 124 Participants |
| Race (NIH/OMB) More than one race | 0 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 0 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 0 Participants |
| Race (NIH/OMB) White | 0 Participants |
| Sex: Female, Male Female | 83 Participants |
| Sex: Female, Male Male | 41 Participants |
Adverse events
| Event type | EG000 affected / at risk |
|---|---|
| deaths Total, all-cause mortality | 0 / 125 |
| other Total, other adverse events | 13 / 125 |
| serious Total, serious adverse events | 0 / 125 |